NCT06730984

Brief Summary

This study plans to enroll 148 patients undergoing upper gastrointestinal endoscopic submucosal dissection (ESD). Patients will be randomly divided into a control group (conventional tracheal intubation) and an experimental group (endoscopy-assisted tracheal intubation). Patients meeting the inclusion criteria and not falling under the exclusion criteria will be invited to participate in the study. Upon providing voluntary consent, the research physician will arrange for the patient's inclusion in the study. After signing the informed consent form, the research physician will collect the patient's basic information, medical history, and other details, followed by timing the preoperative preparation period and evaluating postoperative discomfort

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
132

participants targeted

Target at P50-P75 for not_applicable

Timeline
7mo left

Started Dec 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress70%
Dec 2024Dec 2026

First Submitted

Initial submission to the registry

December 9, 2024

Completed
1 day until next milestone

Study Start

First participant enrolled

December 10, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 12, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 8, 2026

Expected
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2026

Last Updated

December 12, 2024

Status Verified

December 1, 2024

Enrollment Period

2 years

First QC Date

December 9, 2024

Last Update Submit

December 9, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • preoperative preparation time

    the time from Initiate Anesthesia Induction to Insert the Therapeutic Endoscope into the Oral Cavity

    10 mins

Secondary Outcomes (2)

  • The time to view the vocal cords (TVVC)

    1 min

  • The time to advance the tracheal tube into trachea (TATT)

    1 min

Study Arms (2)

Endoscopy-Assisted Tracheal Intubation

EXPERIMENTAL

Tracheal Intubation Under Endoscopic Guidance

Other: Endoscopy-Assisted Tracheal Intubation

Traditional Tracheal Intubation

ACTIVE COMPARATOR

Tracheal Intubation Under Video Laryngoscopy

Other: Traditional Tracheal Intubation

Interventions

Tracheal Intubation Under Endoscopic Guidance

Endoscopy-Assisted Tracheal Intubation

Tracheal Intubation Under Video Laryngoscopy

Traditional Tracheal Intubation

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing endoscopic submucosal dissection (ESD) at Ningbo University Affiliated First Hospital from December 2024 to December 2026.
  • Aged between 18 and 75 years.
  • Patients who voluntarily agree to participate in the study and sign the informed consent form.

You may not qualify if:

  • Individuals under 18 years of age.
  • Patinents unwilling or unable to provide informed consent.
  • Patients with severe chronic cardiac or pulmonary disease, or those who have required hospitalization for coronary or cerebrovascular events or radiotherapy within the past 3 months.
  • Patients with severe abdominal symptoms such as severe pain, bloating, or nausea.
  • Patients with inadequate preoperative preparation.
  • Individuals requiring lifelong anticoagulant therapy, those with severe bleeding disorders, or those who have recently taken anticoagulant or antiplatelet medications.
  • Pregnant or breastfeeding individuals.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

the First Affiliated Hospital of Ningbo University

Ningbo, Zhejiang, 315000, China

Location

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 9, 2024

First Posted

December 12, 2024

Study Start

December 10, 2024

Primary Completion (Estimated)

December 8, 2026

Study Completion (Estimated)

December 10, 2026

Last Updated

December 12, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations